Showing results (2411-2420 of 8,982) with videos related to
Sort By:
Pageof 899
Journal of Hepatology|August 11, 2019
Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis CKate Childs, Christopher Davis, Mary Cannon, et al.Journal of Hepatology|December 1, 1988
The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasoneU Karck, T Peters, K DeckerJournal of Hepatology|December 16, 2003
Studies on the mechanism of accumulation of cholesterol in the gallbladder mucosa. Evidence that sterol 27-hydroxylase is not a pathogenetic factorAnna Strömsten, Sara von Bahr, Sven Bringman, et al.Journal of Hepatology|December 16, 2003
Transcriptional reprogramming in murine liver defines the physiologic consequences of biliary obstructionKathleen M Campbell, Gregg E Sabla, Jorge A BezerraJournal of Hepatology|December 16, 2003
A randomized placebo controlled trial of vitamin E for alcoholic hepatitisEsteban Mezey, James J Potter, Lynda Rennie-Tankersley, et al.Journal of Hepatology|December 16, 2003
Corticosteroids stimulate selectively transforming growth factor (TGF)-beta receptor type III expression in transdifferentiating hepatic stellate cellsLucia Wickert, Muna Abiaka, Ursula Bolkenius, et al.Journal of Hepatology|February 16, 2005
Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patientsJean-Charles Duclos-Vallée, Daniel Vittecoq, Elina Teicher, et al.Journal of Hepatology|February 16, 2005
Amelioration of microcirculatory damage by an endothelin A receptor antagonist in a rat model of reversible acute liver failureDaniel Palmes, Sebastian Skawran, Udo Stratmann, et al.Journal of Hepatology|January 25, 2005
Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238Malika Lasfer, Nathalie Vadrot, Andrew V Schally, et al.Journal of Hepatology|December 4, 2003
Extensive changes in liver gene expression induced by hereditary tyrosinemia type I are not normalized by treatment with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC)Marjanka C Luijerink, Saskia M M Jacobs, Ellen A C M van Beurden, et al.Pageof 899